IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma (Q34440364)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma (English)
1 reference
Maloney DG
1 reference
Grillo-López AJ
1 reference
White CA
1 reference
Bodkin D
1 reference
Schilder RJ
1 reference
Neidhart JA
1 reference
Janakiraman N
1 reference
Foon KA
1 reference
Liles TM
1 reference
Dallaire BK
1 reference
Wey K
1 reference
Royston I
1 reference
Davis T
1 reference
Levy R
1 reference
1 September 1997
1 reference